A primary focus during the early stages of research and development is to minimize future risk. Our comprehensive solution ensures consistent quality from compound optimization and preclinical work through clinical-study sample collection and analysis. Our experience executing protein-binding studies coupled with the application of larger capacity, automated formats delivers high-quality, timely data at excellent value.
- Automated processing
- Custom-built equilibrium dialysis device (500 µL volume) or other commercial plate-based systems
- Equilibrium dialysis
- Radioactive or non-radioactive compounds